News Feature | Published:

What price the Olympian ideal?

Nature volume 407, pages 124127 (14 September 2000) | Download Citation

Subjects

  • A Correction to this article was published on 26 October 2000

Without more money for their research, antidoping scientists will continue to be beaten into second place by pharmaceutically assisted athletes. Alison Abbott reports from the front line of sport's drugs war.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Haematologica 85, 564– 572 (2000).

  2. 2.

    & Nature 405, 635 (2000).

  3. 3.

    et al. J. Clin. Endocrinol. Metab. 84, 3591 – 3601 (1999).

  4. 4.

    , , & Lancet 353, 895 (1999).

  5. 5.

    , & J. Chromatog. B 721, 301– 307 (1999).

Download references

Author information

Affiliations

  1. Alison Abbott is Nature's Senior European Correspondent.

    • Alison Abbott

Authors

  1. Search for Alison Abbott in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/35025272

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing